Showing results (21-30 of 121) with videos related to
Sort By:
Pageof 13
Antiviral Therapy|June 19, 2014
Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferon and ribavirin for chronic hepatitis CEiichi Ogawa, Norihiro Furusyo, Motohiro Shimizu, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 22, 2017
A case of amebiasis with negative serologic markers that caused intra-abdominal abscessRie Tanaka, Norihiro Furusyo, Rinne Takeda, et al.BMC Gastroenterology|April 20, 2010
Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatmentEiichi Ogawa, Norihiro Furusyo, Kazuhiro Toyoda, et al.Diabetes Research and Clinical Practice|January 1, 2014
The utility of urinary myo-inositol as a marker of glucose intoleranceHiroaki Ikezaki, Norihiro Furusyo, Kyoko Okada, et al.JAMA Internal Medicine|December 12, 2022
Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis CEiichi Ogawa, Nicholas Chien, Leslie Kam, et al.AIDS Research and Human Retroviruses|October 21, 2016
The Expression Level of Neutrophil CD64 Is a Useful Marker of Systemic Inflammation Associated with HIV InfectionFujiko Mitsumoto-Kaseida, Masayuki Murata, Kazuya Ura, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 19, 2009
Protein-losing enteropathy during highly active antiretroviral therapy in a patient with AIDS-related disseminated Mycobacterial avium complex infectionEiichi Ogawa, Masayuki Murata, Mami Unno, et al.The Journal of Antimicrobial Chemotherapy|March 12, 2011
Ribavirin concentration in the later stages of 48 week pegylated interferon-alpha2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological responseNorihiro Furusyo, Masayuki Murata, Eiichi Ogawa, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 9, 2014
A case of successful treatment with telaprevir-based triple therapy for hepatitis C infection after treatment failure with vaniprevir-based triple therapyKoji Takayama, Norihiro Furusyo, Eiichi Ogawa, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 30, 2011
Abbott RealTime PCR assay is useful for evaluating virological response to antiviral treatment for chronic hepatitis CHiroaki Ikezaki, Norihiro Furusyo, Takeshi Ihara, et al.Pageof 13